Skip to main content

Table 1 Clinicopathological features and HIWI expression in esophageal squamous cell carcinoma

From: Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis

Parameters

Cases (%)

Cytoplasma

Nucleus

Cytoplasma and Nucleus

  

Low

High

P

Low

High

P

Low

Moderate

High

P

Age

   

0.683

  

0.830

   

0.727

<51

48 (31.4)

21

27

 

31

17

 

13

26

9

 

51-60

52 (34.0)

25

27

 

36

16

 

19

23

10

 

>60

53 (34.6)

21

32

 

37

16

 

14

30

9

 

Gender

   

0.448

  

0.666

   

0.251

Male

93 (60.8)

43

50

 

62

31

 

31

43

19

 

Female

60 (39.2)

24

36

 

42

18

 

15

36

9

 

Location

   

0.813

  

0.311

   

0.556

Upper

14 (9.2)

5

9

 

7

7

 

3

6

5

 

Middle

101 (66.0)

44

57

 

71

30

 

31

53

17

 

Lower

35 (22.9)

16

19

 

24

11

 

11

18

6

 

Missing

3 (2.0)

2

1

 

2

1

 

1

2

0

 

Size

   

0.778

  

0.881

   

0.705

<31 mm

25 (16.3)

11

14

 

18

7

 

7

15

3

 

31-60 mm

105 (68.6)

48

57

 

73

32

 

34

53

18

 

>60 mm

14 (9.2)

5

9

 

9

5

 

4

6

4

 

Missing

9 (5.9)

3

6

 

4

5

 

1

5

3

 

Lymph node metastasis

   

0.904

  

0.232

   

0.593

-

99 (64.7)

43

56

 

64

35

 

27

53

19

 

+

54 (35.3)

24

30

 

40

14

 

19

26

9

 

UICC stage

   

0.074

  

0.148

   

0.662

I

0

0

0

 

0

0

 

0

0

0

 

II

100 (65.4)

49

51

 

64

36

 

32

49

19

 

III

53 (34.6)

18

35

 

40

13

 

14

30

9

 

IV

0

0

0

 

0

0

 

0

0

0

 

T stage

   

0.035*

  

0.278

   

0.002*

I

5 (3.3)

4

1

 

4

1

 

3

2

0

 

II

39 (25.5)

23

16

 

31

8

 

19

16

4

 

III

100 (65.4)

37

63

 

63

37

 

24

52

24

 

IV

9 (5.9)

3

6

 

6

3

 

0

9

  

Histological grade

   

0.011*

  

0.352

   

0.126

Well

53 (34.6)

31

22

 

37

16

 

21

26

6

 

Moderate

60 (39.2)

25

35

 

37

23

 

17

28

15

 

Poor

40 (26.1)

11

29

 

30

10

 

8

25

7

 

Patients at follow-up

   

<0.001*

  

0.981

   

0.001*

Alive

56 (36.6)

35

21

 

38

18

 

27

19

10

 

Dead

97 (63.4)

32

65

 

66

31

 

19

60

18

 
  1. * P < 0.05